AMG 951
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMG 951, covering 2016-06-14 to 2016-06-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab [Phase 2]